US 10954237
JAK inhibitors containing a 4-membered heterocyclic amide
granted A61KA61K31/437A61P
Quick answer
US patent 10954237 (JAK inhibitors containing a 4-membered heterocyclic amide) held by Theravance Biopharma R&D IP, LLC expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/437, A61P, A61P11/00, A61P11/06